Product Details
| Product Name:
MC0704 |
Supply Ability:
10g |
| Release date:
2026/05/11 |
Product Introduction
Bioactivity
| Name | MC0704 |
| Description | MC0704 is a STAT3 inhibitor that demonstrates antitumor activity specifically in mouse breast cancer models, possessing an IC50 value of 2.13 μM. It is effective in inducing cell apoptosis and cell cycle arrest, making it a potential candidate for researching metastatic triple-negative breast cancer (mTNBC). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Inhibitors Related | Flubendazole | HODHBt | Nifuroxazide | Balsalazide disodium dihydrate | Astaxanthin | Cryptotanshinone | Niclosamide | Diosgenin | 2,4,5-Trimethoxybenzoic acid | Niclosamide olamine | Artesunate | Raspberry ketone glucoside |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
-
-
CAS:1621002-23-0
$1980.00
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States